Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

NCT00054210 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel
DRUG: paclitaxel poliglumex

Sponsor

CTI BioPharma